The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation
Abstract In patients with chronic aortic regurgitation (AR), excessive preload and afterload increase left ventricle wall stress, leading to left ventricular systolic dysfunction. Thus, the objective of the present study was to evaluate the effects of the myosin activator omecamtiv mecarbil (OM) on...
Main Authors: | Bachar El Oumeiri, Philippe van deBorne, Géraldine Hubesch, Antoine Herpain, Filippo Annoni, Pascale Jespers, Constantin Stefanidis, Kathleen Mc Entee, Frédéric Vanden Eynden |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.14988 |
Similar Items
-
Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats
by: Bachar El-Oumeiri, et al.
Published: (2018-05-01) -
Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil
by: Bachar El Oumeiri, et al.
Published: (2023-01-01) -
Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil
by: Edgardo Kaplinsky, et al.
Published: (2018-04-01) -
Safety and efficacy of omecamtiv mecarbil for heart failure: A systematic review and meta-analysis
by: Fadel Alqatati, et al.
Published: (2022-05-01) -
Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword
by: Jorik H. Amesz, et al.
Published: (2023-09-01)